Guardion Health Sciences | 8-K: Current report
Guardion Health Sciences | DEFA14A: Others
Guardion Health Sciences | DEFA14A: Others
Guardion Health Sciences | 8-K: Current report
Guardion Health Sciences | 10-Q: Quarterly report
Guardion Health Sciences | 424B5: Prospectus
Guardion Health Sciences | EFFECT: Others
Guardion Health Sciences | 8-K: Current report
Guardion Health Sciences | 10-K/A: Annual report (Amendment)
Guardion Health Sciences | 8-K: Current report
Guardion Health Sciences | DEFM14A: Definitive proxy statement relating to merger or acquisition
Guardion Health Sciences | 3: Initial statement of beneficial ownership of securities-10% Owner GREAT POINT CAPITAL LLC
Guardion Health Sciences | S-3: Registration statement for specified transactions by certain issuers
Guardion Health Sciences | 8-K: Current report
Guardion Health Sciences | 10-K: Annual report
Guardion Health Sciences | PREM14A: Preliminary proxy statements relating to merger or acquisition
Guardion Health Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Guardion Health Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(3.8%),Daniel B. Asher(3.8%), etc.
Guardion Health Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(9.99%),Sander Gerber(9.99%)
Guardion Health Sciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
No Data